Biological characterization of a new subtype-A variant of human immunodeficiency virus type 1 from Nigeria

Authors

  • David O. Olaleye Department of Virology, College of Medicine, University College Hospital, Ibadan
  • Zhijuan Sheng Laboratory of Viral Oncology and AIDS Research, University of Southern California, School of Medicine, 1804 N. Soto St., Los Angeles, CA 90032-3626
  • Thomas Howard Laboratory of Viral Oncology and AIDS Research, University of Southern California, School of Medicine, 1804 N. Soto St., Los Angeles, CA 90032-3626
  • Suraiya Rasheed Laboratory of Viral Oncology and AIDS Research, University of Southern California, School of Medicine, 1804 N. Soto St., Los Angeles, CA 90032-3626

Keywords:

AIDS, HIV-1, Clade A, Macrophage-tropic viruses, Neurotropism

Abstract

We have isolated a new variant of HIV-1 from Nigeria.  The virus was recovered from the peripheral blood mononuclear cells (PBMCs) of an apparently asymptomatic, 23-year old male from Ibadan, Nigeria.  The in vitro host range indicates that this virus is highly cytopathic to normal PBMCs, established T-cell lines and the monocytic cell line U937.  The highest virus titre was obtained in freshly isolated macrophage/monocyte cells which also showed the least cytopathology.  Based on the DNA sequence analysis of cDNA clones containing the env gene, this virus has been classified as HIV-subtype or clade A.  None of the five viruses currently assigned to clade A have been isolated from Nigeria.  The clade A viruses also have not been shown to exhibit extreme cytopathicity of lymphocytes and macrophage tropism observed in the Nigerian strain.  Since most macrophage-tropic viruses have been associated with "neurotropism", the isolation of an HIV-1 strain from the blood of an individual with no known neurological disorders indicates that this unique combination of cell-tropism may be essential for the rapid onset of HIV disease.  This is the first report of an HIV-1 isolate from Nigeria.

Author Biographies

Zhijuan Sheng, Laboratory of Viral Oncology and AIDS Research, University of Southern California, School of Medicine, 1804 N. Soto St., Los Angeles, CA 90032-3626

Laboratory of Viral Oncology and AIDS Research, University of Southern California, School of Medicine, 1804 N. Soto St., Los Angeles, CA 90032-3626

Thomas Howard, Laboratory of Viral Oncology and AIDS Research, University of Southern California, School of Medicine, 1804 N. Soto St., Los Angeles, CA 90032-3626

Laboratory of Viral Oncology and AIDS Research, University of Southern California, School of Medicine, 1804 N. Soto St., Los Angeles, CA 90032-3626

Suraiya Rasheed, Laboratory of Viral Oncology and AIDS Research, University of Southern California, School of Medicine, 1804 N. Soto St., Los Angeles, CA 90032-3626

Laboratory of Viral Oncology and AIDS Research, University of Southern California, School of Medicine, 1804 N. Soto St., Los Angeles, CA 90032-3626

Published

2026-03-11

Issue

Section

Articles